Dose-dependent effects of selenite (Se4+) on arsenite (As3+)-induced apoptosis and differentiation in acute promyelocytic leukemia cells

Cell Death and Disease

Volumn 6, Issue 1, 2015, Pages

  Wang, S ^a   Geng, Z ^a   Shi, N ^a   Li, X ^a   Wang, Z ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; REACTIVE OXYGEN METABOLITE; RETINOIC ACID RECEPTOR ALPHA; SELENITE; ARSENOUS ACID DERIVATIVE; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; SELENIOUS ACID;

APOPTOSIS; ARTICLE; BINDING SITE; CELL CULTURE; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONFORMATIONAL TRANSITION; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; LEUKEMIA CELL; LIGHT SCATTERING; MITOCHONDRION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; RING FINGER MOTIF; SIGNAL TRANSDUCTION; THERAPY EFFECT; ZINC FINGER MOTIF; BIOLOGICAL MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; ARSENITES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MODELS, BIOLOGICAL; ONCOGENE PROTEINS, FUSION; REACTIVE OXYGEN SPECIES; SELENIOUS ACID;

EID: 84927590767     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.563     Document Type: Article

References (41)

1. Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008; 111: 2505-2515.
2. De Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347: 558-561.
3. Zhu J, Lallemand-Breitenbach V, de Thé H. Pathways of retinoic acid- or arsenic trioxideinduced PML/RARα catabolism, role of oncogene degradation in disease remission. Oncogene 2001; 20: 7257-7265.
4. Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J 2003; 79: 391-396.
5. Lengfelder E, Hofmann WK, Nowak D. Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia 2012; 26: 433-442.
6. Tapio S, Grosche B. Arsenic in the aetiology of cancer. Mutat Res 2006; 612: 215-246.
7. Cullen WR. Chemical mechanism of arsenic biomethylation. Chem Res Toxicol 2014; 27: 457-461.
8. Thomas DJ, Styblo M, Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharm 2001; 176: 127-144.
9. Sharma VK, Sohn M. Aquatic arsenic: toxicity, speciation, transformations, and remediation. Environ Int 2009; 35: 743-759.
10. Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 2000; 14: 262-270.
11. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.
12. Yedjou C, Tchounwou P, Jenkins J, McMurray R. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells. J Hematol Oncol 2010; 3: 28.
13. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Gene Dev 1999; 13: 1899-1911.
14. Mathas S, Lietz A, Janz M, Hinz M, Jundt F, Scheidereit C et al. Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis. Blood 2003; 102: 1028-1034.
15. Lemarie A, Morzadec C, Mérino D, Micheau O, Fardel O, Vernhet L. Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factorkappaB-related survival pathway down-regulation. J Pharmacol Exp Ther 2006; 316: 304-314.
16. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 2010; 328: 240-243.
17. Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, Howe K et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J 1995; 14: 1532-1541.
18. Patrick L. Selenium biochemistry and cancer: a review of the literature. Altern Med Rev 2004; 9: 239-258.
19. Li J, Zuo L, Shen T, Xu CM, Zhang ZN. Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: involvement of oxidative stress and mitochondria. J Trace Elem Med Bio 2003; 17: 19-26.
20. Zuo L, Li J, Yang Y, Wang X, Shen T, Xu CM et al. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann Hematol 2004; 83: 751-758.
21. Guan LY, Han BS, Li ZS, Hua FY, Huang F, Wei W et al. Sodium selenite induces apoptosis by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in human acute promyelocytic leukemia NB4 cells. Apoptosis 2009; 14: 218-225.
22. Brenneisen P, Steinbrenner H, Sies H. Selenium, oxidative stress, and health aspects. Mol Aspects Med 2005; 26: 256-267.
23. Zeng H, Uthus EO, Combs GF. Mechanistic aspects of the interaction between selenium and arsenic. J Inorg Biochem 2005; 99: 1269-1274.
24. Darzynkiewicz Z, Zhao H, Halicka HD, Rybak P, Dobrucki J, Wlodkowic D. DNA damage signaling assessed in individual cells in relation to the cell cycle phase and induction of apoptosis. Crit Rev Clin Lab Sci 2011; 49: 199-217.
25. Jakoby M, Schnittger A. Cell cycle and differentiation. Curr Opin Plant Biol 2004; 7: 661-669.
26. Watanabe T, Ohta Y, Mizumura A, Kobayashi Y, Hirano S. Analysis of arsenic metabolites in HepG2 and AS3MT-transfected cells. Arch Toxicol 2011; 85: 577-588.
27. Wang SP, Li XL, Song XL, Geng ZR, Hu X, Wang ZL. Rapid equilibrium kinetic analysis of arsenite methylation catalyzed by recombinant human arsenic (+3 oxidation state) methyltransferase (hAS3MT). J Biol Chem 2012; 287: 38790-38799.
28. Eruslanov E, Kusmartsev S. Identification of ROS using oxidized DCFDA and flowcytometry. Methods Mol Biol 2010; 594: 57-72.
29. Morse D, Choi AMK. Heme oxygenase-1: from bench to bedside. Am J Resp Crit Care 2005; 172: 660-670.
30. Huerta-Olvera SG, Macías-Barragán J, Ramos-Márquez ME, Armendáriz-Borunda J, Díaz-Barriga F, Siller-López F. Alpha-lipoic acid regulates heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cells. Environ Toxicol Phar 2010; 29: 144-149.
31. Song XL, Geng ZR, Li CY, Hu X, Wang ZL. Transition metal ions and selenite modulate the methylation of arsenite by the recombinant human arsenic (+3 oxidation state) methyltransferase (hAS3MT). J Inorg Biochem 2010; 104: 541-550.
32. Yu Z, Reid JC, Yang YP. Utilizing dynamic light scattering as a process analytical technology for protein folding and aggregation monitoring in vaccine manufacturing. J Pharm Sci 2013; 102: 4284-4290.
33. Bi S, Song D, Tian Y, Zhou X, Liu Z, Zhang H. Molecular spectroscopic study on the interaction of tetracyclines with serum albumins. Spectrochim Acta A Mol Biomol Spectrosc 2005; 61: 629-636.
34. Chen SJ, Zhou GB, Zhang XW, Mao JH, de Thé H, Chen Z. From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood 2011; 117: 6425-6437.
35. Shi HL, Shi XL, Liu KJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem 2004; 255: 67-78.
36. Patteson KG, Trivedi N, Stadtman TC. Methanococcus vannielii selenium-binding protein (SeBP): chemical reactivity of recombinant SeBP produced in Escherichia coli. Proc Natl Acad Sci USA 2005; 102: 12029-12034.
37. Ogasawara Y, Lacourciere G, Stadtman TC. Formation of a selenium-substituted rhodanese by reaction with selenite and glutathione: possible role of a protein perselenide in a selenium delivery system. Proc Natl Acad Sci USA 2001; 98: 9494-9498.
38. Jiang GS, Bi KH, Tang TH, Zhang YK, Ren HQ, Jiang FQ et al. Effects of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells. Chin Med J 2003; 116: 1639-1643.
39. Wang SP, Shi N, Geng ZR, Li XL, Hu X, Wang ZL. Inhibitory mechanism of dimercaptopropanesulfonic acid (DMPS) in the cellular biomethylation of arsenic. Biochimie 2014; 106: 167-174.
40. Geng ZR, Song XL, Xing Z, Geng JL, Zhang SC, Zhang XR et al. Effects of selenium on the structure and function of recombinant human S-adenosyl-L-methionine dependent arsenic (+3 oxidation state) methyltransferase in E. coli. J Biol Inorg Chem 2009; 14: 485-496.
41. Wang SP, Geng ZR, Shi N, Li XL, Hu X, Wang ZL. The functions of crucial cysteine residues in the arsenite methylation catalyzed by recombinant human arsenic (III) methyltransferase. PLoS One 2014; 9: e110924.